Holdings
Schwab Health Care Fund
As of Jul 31, 2026, Schwab Health Care Fund reported 80 positions worth US$636M. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 77,841 | US$89.4M | −1,115 | Jul 31, 2026 |
| Johnson & Johnson | 174K | US$44.6M | −19,021 | Jul 31, 2026 |
| Abbvie Inc. | 149K | US$37.3M | −21,968 | Jul 31, 2026 |
| Merck & Company, Inc. | 246K | US$32M | no change | Jul 31, 2026 |
| Unitedhealth Group Incorporated | 73,427 | US$30.4M | +11,143 | Jul 31, 2026 |
| Gilead Sciences, Inc. | 160K | US$20.8M | −24,628 | Jul 31, 2026 |
| Novartis Ag | 120K | US$18.8M | −4,173 | Jul 31, 2026 |
| Amgen Inc. | 43,091 | US$16.6M | −3,530 | Jul 31, 2026 |
| Bristol-myers Squibb Company | 240K | US$15.7M | +119K | Jul 31, 2026 |
| Medtronic Plc. | 172K | US$14.7M | −32,962 | Jul 31, 2026 |